Pacific Biosciences of California (NASDAQ:PACB) Now Covered by Jefferies Financial Group
Analysts at Jefferies Financial Group assumed coverage on shares of Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) in a research note issued on Monday, MarketBeat reports. The brokerage set a “buy” rating and a $4.00 price target on the biotechnology company’s stock. Jefferies Financial Group’s price objective suggests a potential upside of 122.22% […]
More Stories
Vertiv (NYSE:VRT) Shares Up 1.3% – Still a Buy?
Shares of Vertiv Holdings Co (NYSE:VRT – Get Free Report) were up 1.3% during trading on Wednesday . The stock...
Blue Star Gold (CVE:BAU) Shares Down 9.1% – Here’s Why
Blue Star Gold Corp. (CVE:BAU – Get Free Report) fell 9.1% on Friday . The stock traded as low as...
Lam Research (NASDAQ:LRCX) Trading 1.7% Higher – What’s Next?
Shares of Lam Research Co. (NASDAQ:LRCX – Get Free Report) rose 1.7% during mid-day trading on Wednesday . The company...
Kimberly-Clark Co. (NYSE:KMB) Shares Purchased by Strong Tower Advisory Services
Strong Tower Advisory Services boosted its holdings in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 31.3% during the 3rd quarter,...
Hudson Capital Management LLC Has $4.73 Million Stock Position in iShares S&P 500 Value ETF (NYSEARCA:IVE)
Hudson Capital Management LLC lifted its holdings in shares of iShares S&P 500 Value ETF (NYSEARCA:IVE – Free Report) by...
Independence Bank of Kentucky Reduces Position in Starbucks Co. (NASDAQ:SBUX)
Independence Bank of Kentucky decreased its holdings in shares of Starbucks Co. (NASDAQ:SBUX – Free Report) by 21.1% in the...